This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

peer-reviewed publication

trusted source

proofread

Gene-edited calf may reduce reliance on antimicrobials against cattle disease

Gene-edited calf may reduce reliance on antimicrobials against cattle disease
Veterinary epidemiologist Brian Vander Ley of the University of Nebraska-Lincoln's School of Veterinary Medicine and Biomedical Sciences, poses with Ginger, the first gene-edited cow resistant to bovine viral diarrheal virus (BVDV). Credit: Craig Chandler / University Communication / University of Nebraska-Lincoln

Cattle worldwide face major health threats from a highly infectious viral disease that decades of vaccinations and other precautions have failed to contain. Federal, private-sector and University of Nebraska-Lincoln scientists are collaborating on a new line of defense, by producing a gene-edited calf resistant to the virus.

If follow-up research confirms its efficacy, the gene-editing approach offers long-term potential to reduce antimicrobial and in the industry.

The bovine viral diarrhea virus (BVDV) devastates the bovine immune system and can cause severe respiratory and intestinal harm to infected beef and dairy cattle, said veterinary epidemiologist Brian Vander Ley, an associate professor in the University of Nebraska-Lincoln's School of Veterinary Medicine and Biomedical Sciences.

In utero calves are especially vulnerable to infection. If they survive, they can remain infected for life, repeatedly spreading the virus to other cattle.

"They show up as normal cattle, but really, they're shedding a tremendous amount of virus. They're the 'Typhoid Marys' of BVDV spread," said Vander Ley, assistant director of UNL's Great Plains Veterinary Educational Center in Clay Center.

The cattle industry has vaccinated against the disease since the 1960s, but "the highly mutable nature of BVDV and the emergence of highly virulent strains of BVDV contribute to limited success of present control programs," the Academy of Veterinary Consultants has stated.

Scientists identified the specific genetic structure associated with the disease earlier this century. A collaborative project involving scientists with the USDA's Agricultural Research Service and Acceligen, a Minnesota-based private company, used gene editing to change the small number of amino acids that lead to BVDV vulnerability, while keeping the rest of the protein, CD46, unchanged.

Gene-edited calf may reduce reliance on antimicrobials against cattle disease
Veterinary epidemiologist Brian Vander Ley of the University of Nebraska-Lincoln's School of Veterinary Medicine, poses with Ginger, the first gene-edited cow with resistance to bovine viral diarrhea virus (BVDV). Credit: Craig Chandler / University Communication / University of Nebraska-Lincoln

"Our objective was to use gene-editing technology to slightly alter CD46 so it wouldn't bind the virus yet would retain all its normal bovine functions," said Aspen Workman, a scientist with the ARS U.S. Meat Animal Research Center (USMARC) in Clay Center, Nebraska.

A gene-edited calf named Ginger was born on July 19, 2021, and was transported to UNL a week later for close monitoring by Vander Ley. Throughout, Ginger has remained a "bright, healthy calf," normal both physically and behaviorally, which included a week with a BVDV-infected dairy calf that was shedding the virus in great volume.

The research findings are published online May 9 in PNAS Nexus. Workman is lead author.

Ginger is a Gir, a tropically adapted cattle breed used to develop Brahman cattle in North America. Follow-up research will require experimental replication in other cattle breeds. Ginger also will be monitored through pregnancy, if it occurs.

If the gene-editing approach proves viable, it could potentially reduce the cattle sector's use of antimicrobials, Vander Ley said.

"The most successful version of the future that I can see is one where we don't have to deal with antimicrobial resistance because we just don't use that many ," he said. "That's better for everyone. That means that we have eliminated the cause of a lot of the antimicrobial use and we've eliminated that expense for livestock producers."

Michael Heaton, a USMARC researcher for the BVDV project, concurred. This line of research "represents another opportunity to lessen the need for antibiotics in ," he said.

More information: Aspen M. Workman et al, First gene-edited calf with reduced susceptibility to a major viral pathogen, PNAS Nexus (2023). DOI: 10.1093/pnasnexus/pgad125. academic.oup.com/pnasnexus/art … /2/5/pgad125/7157271

Journal information: PNAS Nexus

Citation: Gene-edited calf may reduce reliance on antimicrobials against cattle disease (2023, May 9) retrieved 25 February 2024 from https://phys.org/news/2023-05-gene-edited-calf-reliance-antimicrobials-cattle.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Researchers discover new antimicrobial resistance gene associated with livestock disease treatment

55 shares

Feedback to editors